BRIDGEWAY CAPITAL MANAGEMENT, LLC - SCOPUS BIOPHARMA INC ownership

SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 18 filers reported holding SCOPUS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SCOPUS BIOPHARMA INC
ValueSharesWeighting
Q2 2022$14,000
-70.2%
32,966
-51.5%
0.00%
-100.0%
Q1 2022$47,000
-69.5%
67,966
-27.7%
0.00%
-66.7%
Q4 2021$154,000
-47.6%
93,966
+32.6%
0.00%
-50.0%
Q3 2021$294,000
-12.5%
70,866
+50.7%
0.01%0.0%
Q2 2021$336,000
-15.4%
47,0090.0%0.01%
-14.3%
Q1 2021$397,00047,0090.01%
Other shareholders
SCOPUS BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
M&R CAPITAL MANAGEMENT INC 76,819$33,0000.01%
VANGUARD GROUP INC 54,649$24,0000.00%
UBS Group AG 100$00.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,966$14,0000.00%
Compagnie Lombard Odier SCmA 4,360$2,0000.00%
FIRST MANHATTAN CO. LLC. 25,800$11,0000.00%
WELLS FARGO & COMPANY/MN 89$00.00%
NORTHERN TRUST CORP 12,516$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 217,078$93,0000.00%
View complete list of SCOPUS BIOPHARMA INC shareholders